CILLO, UMBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.600
EU - Europa 5.053
AS - Asia 4.607
SA - Sud America 32
OC - Oceania 19
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 8
Totale 47.336
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 37.554
CN - Cina 2.231
IT - Italia 1.930
SG - Singapore 1.671
FI - Finlandia 805
DE - Germania 605
SE - Svezia 504
VN - Vietnam 422
FR - Francia 323
GB - Regno Unito 311
UA - Ucraina 270
HK - Hong Kong 106
IN - India 103
RU - Federazione Russa 85
IE - Irlanda 59
NL - Olanda 57
CA - Canada 34
ES - Italia 21
JP - Giappone 16
AU - Australia 14
BR - Brasile 14
BE - Belgio 13
CZ - Repubblica Ceca 11
PL - Polonia 11
IL - Israele 10
IR - Iran 8
CH - Svizzera 7
GR - Grecia 7
RO - Romania 7
BZ - Belize 6
CO - Colombia 6
EU - Europa 6
KR - Corea 6
SC - Seychelles 6
AR - Argentina 5
AT - Austria 5
BG - Bulgaria 5
EG - Egitto 5
MX - Messico 5
NZ - Nuova Zelanda 5
TR - Turchia 5
KZ - Kazakistan 4
PH - Filippine 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
CL - Cile 3
ID - Indonesia 3
NO - Norvegia 3
PT - Portogallo 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CI - Costa d'Avorio 2
EE - Estonia 2
LT - Lituania 2
MA - Marocco 2
PE - Perù 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
DK - Danimarca 1
EC - Ecuador 1
HR - Croazia 1
IQ - Iraq 1
KE - Kenya 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
PK - Pakistan 1
SI - Slovenia 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 47.336
Salva come PNG Salva come JPEG
Città #
Fairfield 6.202
Woodbridge 4.087
Houston 3.022
Ann Arbor 2.910
Ashburn 2.644
Chandler 2.584
Seattle 2.295
Cambridge 2.071
Wilmington 2.025
Jacksonville 1.313
Singapore 1.298
Boardman 837
Santa Clara 779
Princeton 744
San Diego 704
Des Moines 489
Beijing 456
Padova 440
Dong Ket 414
Medford 401
Helsinki 379
Nanjing 303
Roxbury 262
Guangzhou 147
Shenyang 136
Nanchang 125
Milan 87
Hebei 85
London 77
New York 75
Jinan 69
Jiaxing 63
Rome 63
Shanghai 62
Falls Church 59
Dublin 57
Redwood City 54
Norwalk 52
Ogden 52
Changsha 50
Dearborn 50
Tianjin 49
Hong Kong 47
Los Angeles 46
Bologna 39
Munich 38
Pune 32
Chicago 28
Kunming 28
Detroit 26
Indiana 26
Zhengzhou 26
Hangzhou 25
Hefei 25
Washington 25
Kharkiv 24
Verona 24
Kilburn 23
Las Vegas 23
Ningbo 23
Taizhou 23
Naples 22
Nürnberg 22
Treviso 22
San Jose 20
Borås 19
Dallas 18
Florence 18
Fuzhou 18
Palermo 18
Lanzhou 17
Rockville 15
Venice 15
Vicenza 15
Prescot 14
Lappeenranta 13
Mumbai 13
Bari 12
Buffalo 12
Frankfurt am Main 12
Hounslow 12
Turin 12
Haikou 11
Nuremberg 11
Taiyuan 11
Hanover 10
Modena 10
Phoenix 10
Southwark 10
Tappahannock 10
Acton 9
Chiswick 9
Esslingen am Neckar 9
Paris 9
Portici 9
San Francisco 9
Toronto 9
Udine 9
Brescia 8
Brno 8
Totale 39.132
Salva come PNG Salva come JPEG
Nome #
TRAPIANTO DI FEGATO CON EMITRASPOSIZIONE PORTO-CAVALE IN PAZIENTE CON BASM SYNDROME 690
Importance of primary indication and liver function between stages: Results of a multicenter Italian audit of ALPPS 2012-2014 173
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial 169
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study. 166
Treatment of hepatocellular carcinoma in the Precision Medicine era: from treatment stage migration to therapeutic hierarchy 166
Cavoportal hemitransposition associated to portoportal anastomosis for liver transplant in portomesenteric thrombosis. 165
Circulating free DNA in the progression of liver damage to hepatocellular carcinoma 161
Alcohol abuse and de novo tumors in liver transplantation 161
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation:the first report on the application of VAC therapy 157
Model for end-stage liver disease-sodium and survival benefit in liver transplantation. 154
Use of N-acetylcysteine during liver procurement: A prospective randomized controlled study. 154
Prognostic impact of model for end-stage liver disease score in patients undergoing liver transplantation with suboptimal livers. 152
Validation of the BCLC prognostic system in surgical hepatocellular cancer patients. 150
A National Mandatory-Split Liver Policy: A Report from the Italian Experience 148
When to perform hepatic resection for intermediate-stage hepatocellular carcinoma 148
Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience. 148
Prognostic Evaluation of the Donor Risk Index Among a Prospective Cohort of Italian Patients Undergoing Liver Transplantation 147
Prospective validation of the Barcelona Clinic Liver Cancer staging system 147
Fulminant hepatic failure: the issue of patient selection for hazardous liver assistance 146
Courage and representations of death in patients who are waiting for a liver transplantation 146
A New Liver Autotransplantation Technique Using Subnormothermic Machine Perfusion for Organ Preservation in a Porcine Model 145
Administration of hepatic stimulatory substance alone or with other liver growth factors does not ameliorate acetaminophen-induced liver failure. 144
Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma 144
Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features 143
Torque Teno Virus: any pathological role in liver transplanted patients? 140
Sequential versus "ab initio' combined diuretic treatment of moderate ascites in cirrhotic patients: Final results of a randomized controlled multicenter clinical study 139
A new experimental model of isolated perfused pig liver to support acute hepaticfailure. 139
Isoniazid-related fulminant hepatic failure in a child: assessment of the native liver's early regeneration after auxiliary partial orthotopic liver transplantation. 139
Cost-effectiveness of Pre-Transplant Sofosbuvir for Preventing Recurrent HCV Infection after Liver Transplantation. 138
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial 135
Human Liver Autofluorescence: An Intrinsic Tissue Parameter Discriminating Normal and Diseased Conditions 134
A PRIORITIZATION MODEL FOR LIVER TRANSPLANTATION BASED ON A DUAL WAITING LIST: A PROSPECTIVE CONTROLLED STUDY 134
Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis 134
Adjuvant chemotherapy for transplanted hepatocellular carcinoma patients: impact on survival or HCV recurrence timing 134
Reply: The easiest way to improve the outcome of suboptimal liver grafts 133
Representing Subnormothermic Machine Perfusion in Fatty Livers: The Complete Picture? 133
Hepatitis C Virus Adversely Affects Quality of Life 132
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 132
The survival benefit of liver transplantation in hepatocellular carcinoma patients 131
Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: A new exception to MELD score in the allocation system to liver transplantation? 131
Successful transplantation of an injured liver 130
Cross-talk between PDGF and S1P signalling elucidates the inhibitory effect and potential antifibrotic action of the immunomodulator FTY720 in activated HSC-cultures. 130
Double autologous bone marrow transplantation and orthotopic liver transplantation in a patient with primary light chain (AL) amyloidosis. 129
The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? 129
Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignancies. 129
Multicentre evaluation of case volume in minimally invasive hepatectomy 129
The two faces of hepatocellular carcinoma prognostic evaluation: 'observational' or 'pragmatic' approach? 129
12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. 128
Nonadherent Behaviors After Solid Organ Transplantation 128
A comparative prospective study of two available solutions for kidney and liver preservation 128
A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation 128
Prognostic role of BAP-1 and PBRM-1 expression in intrahepatic cholangiocarcinoma 128
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy 128
Liver Resection Associated With Mini Porto-Caval Shunt as Salvage Treatment in Patients With Progression of Hepatocellular Carcinoma Before Liver Transplantation: A Case Report 127
Growth hormone/insulin-like growth factor 1 axis recovery after liver transplantation: A preliminary prospective study 127
Psychosocial Support in Liver Transplantation: A Dyadic Study With Patients and Their Family Caregivers 127
Hepatic Resection for Disappearing Liver Metastasis: a Cost-Utility Analysis 126
Covert hepatic encephalopathy: agreement and predictive validity of different indices 125
Liver radiofrequency ablation as emergency treatment for a ruptured hepatocellular carcinoma: a case report 125
Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the milan criteria 124
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation: the first report on the application of VAC therapy 124
Microwave Thermal Ablation for Hepatocarcinoma: Six Liver Transplantation Cases 124
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study 124
Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation. 123
Laparoscopic Ablation of Hepatocellular Carcinoma in Cirrhotic Patients Unsuitable for Liver Resection or Percutaneous Treatment: A Cohort Study 123
Donor-Model for End-Stage Liver Disease and Donor-Recipient Matching in Liver Transplantation 122
Alphafetoprotein and Transplant Survival Benefit For Patients With Hepatocellular Carcinoma: A Multicentre Cohort Study 122
A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation. 122
Laparoscopic microwave thermal ablation for late recurrence of local hepatocellular carcinoma after liver transplant: case report. 122
A Multistep, Consensus-Based Approach to Organ Allocation in Liver Transplantation: Toward a "blended Principle Model" 122
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals. 122
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. 122
Surgery for cholangiocarcinoma 121
Extraordinary disease-free survival in a rare malignant extrarenal rhabdoid tumor: A case report and review of the literature 121
Percutaneous radiofrequency thermal ablation for hepatocellular carcinoma. 121
Predictors of unresectability in hepatoblastoma: A 20-year single centre report 120
Syngeneic living-donor liver transplantation for hemangioendothelioma: a clinical model for studying liver regeneration 120
Antibiotic prophylaxis for preventing postorthotopic liver transplant tuberculosis: is there a safe alternative to isoniazid? 120
Neoadjuvant sirolimus for a large hepatic perivascular epithelioid cell tumor (PEComa) 120
Correction to: Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry (Updates in Surgery, (2017), 69, 3, (271-283), 10.1007/s13304-017-0489-x) 120
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 120
Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER study 120
Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine. 119
EXTREME MARGINAL DONOR: SEVERE HYPOTHERMIA AS A RARE PRESERVATION CONDITION FOR EXPLANTABLE ORGANS - A CASE REPORT 119
Meld-na and Survival Benefit In Liver Transplantation 119
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC 119
Tacrolimus-based dual therapy is as efficacious and safe as the conventional tacrolimus-based triple therapy in liver transplantation 118
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation: the first report on the application of VAC therapy 118
Long-Term Follow-Up and Outcome of Liver Transplantation From Anti-Hepatitis C Virus-Positive Donors: A European Multicentric Case-Control Study 118
Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization. 118
Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapies. 117
Short-term outcomes of pediatric liver transplant recipients after transition to Adult Healthcare Service 117
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. 117
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 117
Central Nervous System Infectious Complications Early After Liver Transplantation 116
TRAPIANTO DI FEGATO PER EPATOCOLANGIOCARCINOMA INCIDENTALE: ESPERIENZA DI CENTRO 116
Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies 116
Including Relative Adrenal Insufficiency in Definition and Classification of Acute-on-Chronic Liver Failure 116
146 EARLY INTRODUCTION OF EVEROLIMUS IN DE NOVO LIVER TRANSPLANTATION: A MULTICENTER RANDOMIZED CLINICAL TRIAL (EPOCAL) 116
Survival Benefit of Transplantation for Recurrence of Hepatocellular Carcinoma After Liver Resection 115
Totale 13.722
Salva come PNG Salva come JPEG
Categoria #
all - tutte 182.566
article - articoli 160.844
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 577
Totale 343.987
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.157 0 0 0 0 0 0 965 1.083 1.082 997 636 394
2020/20217.095 394 576 411 566 272 472 397 632 915 800 793 867
2021/20228.287 238 898 985 522 319 537 1.229 661 353 180 934 1.431
2022/20235.746 1.133 523 108 682 872 826 121 402 717 53 230 79
2023/20243.362 201 492 349 262 222 276 254 193 142 222 354 395
2024/20254.380 46 925 642 508 1.733 444 82 0 0 0 0 0
Totale 47.876